CD45RO expression on peripheral lymphocytes as a prognostic marker for adult T-cell leukemia

Leukemia and Lymphoma

Volumn 28, Issue 5-6, 1998, Pages 583-590

  Suzuki, Muneou ^a   Matsuoka, Hitoshi ^b   Yamashita, Kiyoshi ^c   Maeda, Koichi ^a   Kawano, Kiyohide ^b   Uno, Hisamitsu ^c   Tsubouchi, Hirohito ^a  

^a Miyazaki Medical College   (Japan)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Kure Kyosai Hospital   (Japan)

Author keywords

ATL; CD45RO; Flowcytometry; Prognosis

Indexed keywords

CALCIUM ION; CD45 ANTIGEN; LACTATE DEHYDROGENASE; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE ACTIVATION; LYMPHOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; T CELL LEUKEMIA; TUMOR IMMUNITY;

EID: 0031898966     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058367     Document Type: Article

References (29)

1. Trowbridge, I. S. (1994). CD45: An emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Anna Rev Immunol, 12, 85-116.
2. Worner, I., Matutes, E., Beverley, P. C. L. and Catovsky, D. (1990). The distribution of CD45R, CD29 and CD45RO (UCHL-1 ) antigens in mature CD4 positive T-cell leukaemias. BrJHaematol, 74,4399-4444.
3. Yamashita, N., Buillington, R. and Clement, L. T. (1990). Equipment helper function of human 'naive' and 'memory' CD4 T cells for the generation of alloreactive cytotoxic T lymphocytes. J Clinic Immwwl, 10, 237-246.
4. Morimoto, C, Letvin, N. L., Distaso, J. A., Aldrich, W. R. and Schlossman, S. F. (1985). The isolation and characterization of the human suppressor inducer T-cell subset. J Immunol, 134,1508-1515.
5. Smith, S. H., Brown, M. H., Rowe, D., Callard, R. E. and Beverley, P. C. L. (1986). Functional subsets of human helperinducer cells defined by a new monoclonal antibody, UCHL1. Immunology, 58, 63-70.
6. Jong, R., Brouwer, M., Miedema, F. and Lier, R. A. W. (1991). Human CDS lymphocytes can be divided into CD45RA and CD45RO+ cells with different requirements for activation and differentiation. J Immunol, 146, 2088-2094.
7. Akbar, A. N., Terry, L., Timms, A., Beverley, P. C. L. and Janossy, G. (1988). Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T-cells. J Immunol, 140, 2171-2178.
8. Kong, Y. Y., Kishihara, K., Sumichika, H., Nakamura, T., Kaneko, M. and Nomoto, K. (1995). Differential requirement of CD45 for lymphocyte development and function. Eur J Immunol, 25, 3431-3436.
9. Torimoto, Y., Dang, N. H., Streuli, M., Rothstein, D. M., Saito, H., Schlossman, S. F. and Morimoto, C. (1992). Activation of T-cells through a T-cell-specific epitope of CD45. Cell Immunol, 145, 111-129.
10. Thomas, T. W. and Thomas, M. L. (1993). The leukocyte common antigen, CD45 and other protein tyrosine phosphatases in hematopoielic cells. Cell Biology, 4,409-118.
11. Shimoyama, M. and members of the Lymphoma Study Group (1984-1987). (1991). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br. J Haematol, 79,428-437.
12. Shimoyama, M., Takatsuki, K., Araki, K. and members of the Lymphoma Study Group (1984-1987). (1991). Major prognostic factors of patients with adult T-cell leukemialymphoma: a cooperative study. Leukemia Research, 15, 81-90.
13. Uozumi, K., Hanada, S., Ohno, S., Ishitsuka, K., Shimotakahara, S., Otsuka, M., Chyuman, Y., Nakahara, K., Takeshita, T., Kuwazuru, Y., Saito, T., Makino, T., Iwahashi, M., Utsunomiya, A. and Arima, T. (1995). Combination chemotherapy. (RCM Protocol: Response-Oriented Cyclic Multidrug Protocol) for the acute or lymphoma type adult T-cell leukemia. Leukemia and Lymphoma, 18, 317-323.
14. Tamura, K., Okayama, A., Koga, K., Sagawa, K., Seita, M., Tachibana, N. and Tsuda, K. (1983). Total body irradiation as a primary treatment for adult T-cell leukemia. Jpn J Clinical Oncol, 13 (Supplement 2), 313-324.
15. Tamura, K., Makino, S., Araki, Y., Imamura, T. and Seita, M. (1987). Recombinant Interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer, 59,1059-1062.
16. Suzumiya, J., Marutsuka, K., Nabeshima, K., Nawa, Y., Koono, M., Tamura, K., Kimura, N., Hisano, S., Tachibana, N., Inoue, S. and Sumiyoshi, A. (1993). Autopsy findings in 47 cases of adult T-cell leukemia/lymphoma in Miyazaki prefecture, Japan. Leukemia and Lymphoma, 11,281-286.
17. Kamihira, S., Shoda, H., Atogami, S., Toriya, K., Yamada, Y., Tsukazaki, K., Momita, S., Ikeda, S., Kusano, M., Amagasaki, T., Kinoshita, K. and Tomonaga, M. (1992). Phenotypic diversity and prognosis of adult T-cell leukaemia. Leukemia Research, 16,435 41.
18. Shirono, K., Hattori, T. and Takatsuki, K. (1994). A new classification of clinical stages of adult T-cell leukemia based on prognosis of disease. Leukemia, 8, 1834-1837.
19. Yamada, Y., Ohmoto, Y., Murata, K., Tsukasaki, K., Momota, S., Kamihira, S., Atogami, S., Sohda, H., Moriuchi, Y., Itoyama, T., Kohno, T., Hâta, T., Yamamura, M., Maeda, T., Jubashi, T. and Tomonaga, M. (1994). Increased plasma M-CSF concentration in patients with adult T-cell leukemia: Clinical correlation. Leukemia and Lymphoma, 14, 151-156.
20. Schiavone, E. M., Pardo, C. L., Noto, R. D., Manzo, C., Ferrara, F., Vacca, C. and Vecchio, L. D. (1995). Expression of the leucocyte common antigen (LCA, CD45) isoforms RA and RO in acute haematological malignancies: possible relevance in the definition of new overlap points between normal and leukaemic haemopoiesis. Br J Haemalol, 91, 899-906.
21. Kawano, S., Tatsumi, E., Yoneda, N., Tani, A. and Nakamura, F. (1995). Expression pattern of CD45 RA/RO isoformic antigens in T-lineage neoplasms. American J Hematol, 49,6-14.
22. Suzuki, M., Uno, H., Yamashita, K., Toyama, T., Kubuki, Y., Maeda, K., Matsuoka, H., Ohtaki, S. and Tsubouchi, H. (1996). Clinical significance of CD45RO expression on peripheral blood mononuclear cells in HTLV-I-infected individuals. Br J Haemalol, 92,401-409.
23. Maeda, Y., Matsuda, M., Irimajiri, K. and Horiuchi, A. (1994). Down-regulation of CD3 antigen on adult T-cell leukemia cells. Leukemia and Lymphoma, 13,249-256.
24. Uchiyama, T., Ishikawa, T. and Imura, A. (1995). Adhesion properties of adult T-cell leukemia cell. Leukemia and Lymphoma, 16, 407-412.
25. Uno, H., Matsuoka, H., Suzuki, M., Tsuda, K. and Tsubouchi, 11. (1995). Altered expression of class I HLA antigen on peripheral mononuclear cells in patients with adult T-cell leukemia: inverse relationship with natural killer susceptibility. Cancer Epidemiology, Biomarkers and Prevention, 4, 367-372.
26. Kannagi, M., Matsushita, S., Shida, H. and Harada, S. (1994). Cytotoxic T-cell response and expression of the target antigen in HTLV-I infection. Leukemia, 8 Supplement l, S54-59.
27. Kannagi, M., Matsushita, S. and Harada, S. (1993). Expression of the target antigen for cytotoxic T-lymphocytes on adult T-cell leukemia cells. International J Cancer, 54, 582-588.
28. Katahira, Y., Yashiki, S., Fujiyoshi, T., Nomura, K., Tara, M., Mori, M., Kanzaki, T., Shida, H. and Sonoda, S. (1995). In vitro induction of cytotoxic T-lymphocytes against HTLVI-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn J Cancer Research, 86, 21-27.
29. Frolova, E. A., Richards, S. J., Jones, R. A., Rawstron, A., Master, P. S., Teasdale, J., Short, M., Jack, A. S. and Scott, C. S. (1995). Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-Cell chronic lymphocytic leukaemia (B-CLL). Leukemia and Lymphoma, 16, 307-318.